(OVID) - FDA

(OVID) – FDA

Oct 18, 2023 08:01 AM Ovid Therapeutics (OVID) and Ligand Pharmaceuticals (LGND) Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid’s Cash Runway into 2026
Apr 27, 2023 02:31 PM Ovid Therapeutics (OVID) Announces Long-term Safety & Efficacy Findings from Soticlestat Open Label Extension Study Presented by Takeda
Apr 19, 2021 08:21 AM
Mar 3, 2021 07:05 AM
Dec 1, 2020 04:53 PM
Sep 30, 2020 08:05 AM
Aug 25, 2020 07:14 AM
Aug 25, 2020 07:04 AM
Jul 13, 2020 07:02 AM
Jun 19, 2020 08:03 AM
May 7, 2020 07:48 AM
Sep 23, 2019 07:07 AM
Sep 12, 2019 08:07 AM
Jul 2, 2019 08:05 AM
Jun 27, 2019 08:09 AM
Dec 17, 2018 06:02 AM
Dec 6, 2018 08:02 AM
Sep 24, 2018 08:32 AM
Aug 16, 2018 04:04 PM
Aug 6, 2018 07:02 AM
Jul 18, 2018 07:31 AM
Jul 11, 2018 07:32 AM
Mar 15, 2018 08:00 AM
Dec 20, 2017 08:01 AM
Dec 19, 2017 08:01 AM
Dec 5, 2017 08:04 AM
Nov 28, 2017 04:01 PM
Oct 16, 2017 08:05 AM
Oct 10, 2017 08:05 AM
Oct 6, 2017 06:58 AM
Aug 21, 2017 08:14 AM